EULAR response criteria for polymyalgia rheumatica: Results of an initiative of the European Collaborating Polymyalgia Rheumatica Group (subcommittee of ESCISIT)

B. F. Leeb, H. A. Bird, G. Nesher, I. Andel, W. Hueber, D. Logar, C. M. Montecucco, J. Rovensky, J. Sautner, M. Sonnenblick

Research output: Contribution to journalArticle

Abstract

Objective: To develop response criteria for polymyalgia rheumatica (PMR) for monitoring treatment and comparing alternative treatments regimens. Methods: 76 patients, mean (SD) age 68.7 (7.7) years, were enrolled. Corticosteroids, and non-steroidal anti-inflammatory drugs (NSAIDs) were the only drugs allowed during the observation period. Erythrocyte sedimentation rate (ESR), C reactive protein (CRP), α2 globulin, serum iron, pain, physician's global assessment (PGA), morning stiffness (MST), muscle tenderness (MT), myalgia, and the elevation of upper limbs (EUL) were determined regularly. The daily corticosteroid and NSAID doses as the corticosteroid response time were recorded. To ensure evaluation of an adequate number of patients (n = 57) week 24 was chosen for final analysis. Results: ESR, CRP, α2 globulin, pain, PGA, MST, myalgia, MT, and EUL showed significant improvement (p2 globulin (p = 0.13), MST (p = 0.1), and MT (p = 0.07) were independent of pain, but myalgia (p

Original languageEnglish
Pages (from-to)1189-1194
Number of pages6
JournalAnnals of the Rheumatic Diseases
Volume62
Issue number12
DOIs
Publication statusPublished - Dec 2003

Fingerprint

Polymyalgia Rheumatica
Myalgia
Muscle
Adrenal Cortex Hormones
Stiffness
Globulins
Sedimentation
C-Reactive Protein
Anti-Inflammatory Agents
Pharmaceutical Preparations
Serum Globulins
Blood Sedimentation
Upper Extremity
Pain
Iron
Physicians
Monitoring
Reaction Time
Observation
Therapeutics

ASJC Scopus subject areas

  • Rheumatology
  • Immunology

Cite this

EULAR response criteria for polymyalgia rheumatica : Results of an initiative of the European Collaborating Polymyalgia Rheumatica Group (subcommittee of ESCISIT). / Leeb, B. F.; Bird, H. A.; Nesher, G.; Andel, I.; Hueber, W.; Logar, D.; Montecucco, C. M.; Rovensky, J.; Sautner, J.; Sonnenblick, M.

In: Annals of the Rheumatic Diseases, Vol. 62, No. 12, 12.2003, p. 1189-1194.

Research output: Contribution to journalArticle

Leeb, B. F. ; Bird, H. A. ; Nesher, G. ; Andel, I. ; Hueber, W. ; Logar, D. ; Montecucco, C. M. ; Rovensky, J. ; Sautner, J. ; Sonnenblick, M. / EULAR response criteria for polymyalgia rheumatica : Results of an initiative of the European Collaborating Polymyalgia Rheumatica Group (subcommittee of ESCISIT). In: Annals of the Rheumatic Diseases. 2003 ; Vol. 62, No. 12. pp. 1189-1194.
@article{0862b0d72765492fa60d043676381da7,
title = "EULAR response criteria for polymyalgia rheumatica: Results of an initiative of the European Collaborating Polymyalgia Rheumatica Group (subcommittee of ESCISIT)",
abstract = "Objective: To develop response criteria for polymyalgia rheumatica (PMR) for monitoring treatment and comparing alternative treatments regimens. Methods: 76 patients, mean (SD) age 68.7 (7.7) years, were enrolled. Corticosteroids, and non-steroidal anti-inflammatory drugs (NSAIDs) were the only drugs allowed during the observation period. Erythrocyte sedimentation rate (ESR), C reactive protein (CRP), α2 globulin, serum iron, pain, physician's global assessment (PGA), morning stiffness (MST), muscle tenderness (MT), myalgia, and the elevation of upper limbs (EUL) were determined regularly. The daily corticosteroid and NSAID doses as the corticosteroid response time were recorded. To ensure evaluation of an adequate number of patients (n = 57) week 24 was chosen for final analysis. Results: ESR, CRP, α2 globulin, pain, PGA, MST, myalgia, MT, and EUL showed significant improvement (p2 globulin (p = 0.13), MST (p = 0.1), and MT (p = 0.07) were independent of pain, but myalgia (p",
author = "Leeb, {B. F.} and Bird, {H. A.} and G. Nesher and I. Andel and W. Hueber and D. Logar and Montecucco, {C. M.} and J. Rovensky and J. Sautner and M. Sonnenblick",
year = "2003",
month = "12",
doi = "10.1136/ard.2002.002618",
language = "English",
volume = "62",
pages = "1189--1194",
journal = "Annals of the Rheumatic Diseases",
issn = "0003-4967",
publisher = "BMJ Publishing Group",
number = "12",

}

TY - JOUR

T1 - EULAR response criteria for polymyalgia rheumatica

T2 - Results of an initiative of the European Collaborating Polymyalgia Rheumatica Group (subcommittee of ESCISIT)

AU - Leeb, B. F.

AU - Bird, H. A.

AU - Nesher, G.

AU - Andel, I.

AU - Hueber, W.

AU - Logar, D.

AU - Montecucco, C. M.

AU - Rovensky, J.

AU - Sautner, J.

AU - Sonnenblick, M.

PY - 2003/12

Y1 - 2003/12

N2 - Objective: To develop response criteria for polymyalgia rheumatica (PMR) for monitoring treatment and comparing alternative treatments regimens. Methods: 76 patients, mean (SD) age 68.7 (7.7) years, were enrolled. Corticosteroids, and non-steroidal anti-inflammatory drugs (NSAIDs) were the only drugs allowed during the observation period. Erythrocyte sedimentation rate (ESR), C reactive protein (CRP), α2 globulin, serum iron, pain, physician's global assessment (PGA), morning stiffness (MST), muscle tenderness (MT), myalgia, and the elevation of upper limbs (EUL) were determined regularly. The daily corticosteroid and NSAID doses as the corticosteroid response time were recorded. To ensure evaluation of an adequate number of patients (n = 57) week 24 was chosen for final analysis. Results: ESR, CRP, α2 globulin, pain, PGA, MST, myalgia, MT, and EUL showed significant improvement (p2 globulin (p = 0.13), MST (p = 0.1), and MT (p = 0.07) were independent of pain, but myalgia (p

AB - Objective: To develop response criteria for polymyalgia rheumatica (PMR) for monitoring treatment and comparing alternative treatments regimens. Methods: 76 patients, mean (SD) age 68.7 (7.7) years, were enrolled. Corticosteroids, and non-steroidal anti-inflammatory drugs (NSAIDs) were the only drugs allowed during the observation period. Erythrocyte sedimentation rate (ESR), C reactive protein (CRP), α2 globulin, serum iron, pain, physician's global assessment (PGA), morning stiffness (MST), muscle tenderness (MT), myalgia, and the elevation of upper limbs (EUL) were determined regularly. The daily corticosteroid and NSAID doses as the corticosteroid response time were recorded. To ensure evaluation of an adequate number of patients (n = 57) week 24 was chosen for final analysis. Results: ESR, CRP, α2 globulin, pain, PGA, MST, myalgia, MT, and EUL showed significant improvement (p2 globulin (p = 0.13), MST (p = 0.1), and MT (p = 0.07) were independent of pain, but myalgia (p

UR - http://www.scopus.com/inward/record.url?scp=10744219715&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=10744219715&partnerID=8YFLogxK

U2 - 10.1136/ard.2002.002618

DO - 10.1136/ard.2002.002618

M3 - Article

C2 - 14644857

AN - SCOPUS:10744219715

VL - 62

SP - 1189

EP - 1194

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

SN - 0003-4967

IS - 12

ER -